摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,5-二氢苯丙氨酸 | 16055-12-2

中文名称
2,5-二氢苯丙氨酸
中文别名
——
英文名称
L-2,5-dihydrophenylalanine
英文别名
2,5-Dihydrophenylalanine;(2S)-2-amino-3-cyclohexa-1,4-dien-1-ylpropanoic acid
2,5-二氢苯丙氨酸化学式
CAS
16055-12-2
化学式
C9H13NO2
mdl
——
分子量
167.208
InChiKey
FSZMHEMPLAVBQZ-QMMMGPOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.6
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    63.3
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2922499990

SDS

SDS:5c96d02ccaa175566b898d959d6a8e3a
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,5-二氢苯丙氨酸sodium hydroxide1-羟基苯并三唑一水物N,N'-二环己基碳二亚胺 作用下, 以 二氯甲烷 为溶剂, 反应 8.75h, 生成 N-benzoyl-N'-(D-α-methylbenzyl)-(cyclohexa-1,4-dienyl)-L-alaninamide
    参考文献:
    名称:
    Ozonolysis of (cyclohexa-1,4-dienyl)-L-alanine. An approach to the synthesis of new unnatural amino acids. X-Ray molecular structure of 2-hydroxy-7-methyl-3-phenylpyrazolo[1,5-a]pyrimidine
    摘要:
    The aromatic ring in L-phenylalanine was transformed into isoxazolyl, N-phenylpyrazolyl, and the bicyclic pyrazolo[1,5-a]pyrimidinyl groups, by a combination of Birch reduction and ozonolysis, followed by condensation with the relevant binucleophiles. The ozonolysis was carried out on the N-acylated esters of cyclohexa-1,4-dienylalanine. The resulting N-acylated esters of heterocyclic alanine derivatives were obtained without isolation of the ozonolysis products. 4-Phenylpyrazolidine-3,5-dione was used as a 'hydrazine donor' in the construction of a pyrazolyl group, as direct condensation with hydrazine was successful.
    DOI:
    10.1039/p19950002509
  • 作为产物:
    描述:
    L-苯丙氨酸lithium 作用下, 以 叔丁醇 为溶剂, 生成 2,5-二氢苯丙氨酸
    参考文献:
    名称:
    Ozonolysis of (cyclohexa-1,4-dienyl)-L-alanine. An approach to the synthesis of new unnatural amino acids. X-Ray molecular structure of 2-hydroxy-7-methyl-3-phenylpyrazolo[1,5-a]pyrimidine
    摘要:
    The aromatic ring in L-phenylalanine was transformed into isoxazolyl, N-phenylpyrazolyl, and the bicyclic pyrazolo[1,5-a]pyrimidinyl groups, by a combination of Birch reduction and ozonolysis, followed by condensation with the relevant binucleophiles. The ozonolysis was carried out on the N-acylated esters of cyclohexa-1,4-dienylalanine. The resulting N-acylated esters of heterocyclic alanine derivatives were obtained without isolation of the ozonolysis products. 4-Phenylpyrazolidine-3,5-dione was used as a 'hydrazine donor' in the construction of a pyrazolyl group, as direct condensation with hydrazine was successful.
    DOI:
    10.1039/p19950002509
点击查看最新优质反应信息

文献信息

  • Phenylalanine – a biogenic ligand with flexible η6- and η6:κ1-coordination at ruthenium(ii) centres
    作者:Thomas Reiner、Dominik Jantke、Xiao-He Miao、Alexander N. Marziale、Florian J. Kiefer、Jörg Eppinger
    DOI:10.1039/c3dt50589h
    日期:——
    The reaction of (S)-2,5-dihydrophenylalanine 1 with ruthenium(III) chloride yields the μ-chloro-bridged dimeric η6-phenylalanine ethyl ester complex 3, which can be converted into the monomeric analogue, η6:κ1-phenylalanine ethyl ester complex 12, under basic conditions. Studies were carried out to determine the stability and reactivity of complexes bearing η6- and η6:κ1-chelating phenylalanine ligands under various conditions. Reaction of 3 with ethylenediamine derivatives N-p-tosylethylenediamine or 1,4-di-N-p-tosylethylenediamine results in the formation of monomeric η6:κ1-phenylalanine ethyl ester complexes 14 and 15, which could be saponified yielding complexes 16 and 17 without changing the inner coordination sphere of the metal centre. The structure of η6:κ1-phenylalanine complex 17 and an N-κ1-phenylalanine complex 13 resulting from the reaction of 3 with an excess of pyridine were confirmed by X-ray crystallography.
    (S)-2,5-二氢苯丙氨酸1与氯化钌(III)的反应生成γ-氯桥联二聚体Γ6-苯丙氨酸乙酯络合物3,后者在碱性条件下可转化为单体类似物Γ6:Γ1-苯丙氨酸乙酯络合物12。研究人员对Γ6-和Γ6:Γ1-螯合苯丙氨酸配体在各种条件下的稳定性和反应性进行了研究。3与乙二胺衍生物N-对甲苯磺酰乙二胺或1,4-二-N-对甲苯磺酰乙二胺的反应生成单体Γ6:Γ1-苯丙氨酸乙酯络合物14和15,后者可皂化生成络合物16和17,而不会改变金属中心的内配位层。Γ6:Γ1-苯丙氨酸络合物17和N-Γ1-苯丙氨酸络合物13的结构通过X射线晶体学得到了证实,它们是由3与过量吡啶反应生成的。
  • L-Aspartyl dipeptides as sweetening agents
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US03978034A1
    公开(公告)日:1976-08-31
    Dipeptides of the formula: ##EQU1## wherein n is an integer from 0 to 5, R.sub.1 is an alkyl, alkylaryl or alicyclic radical, and R.sub.2 is a cycloalkenyl radical, and, in addition, may be phenyl when n is 0. The carbon marked with an asterisk is always of the L-configuration. These compounds have a sweet taste and are useful as sweetening agents.
    化学式为:##EQU1## 其中n为0到5的整数,R1为烷基、烷基芳基或脂环基,R2为环烯基基团,此外,当n为0时,R2可以为苯基。标有星号的碳原子始终为L-构型。这些化合物具有甜味并可用作甜味剂。
  • Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides
    申请人:Ryan, James Walter
    公开号:EP0073143A2
    公开(公告)日:1983-03-02
    Novel inhibitors of angiotensin converting enzyme are disclosed which have the general formula wherein R, and/or R3 form complex amides and imides thereof, X = S, O or NR3, R4 and Rs form with -N-C- a 4-6 membered ring structure as described and the other R substituents are selected from a variety of disclosed groups.
    已公开的新型血管紧张素转换酶抑制剂具有通式 其中 R 和/或 R3 形成其复合酰胺和亚胺,X = S、O 或 NR3,R4 和 Rs 与 -N-C- 形成所述的 4-6 分子环结构,其他 R 取代基选自各种已公开的基团。
  • Consistent chew texture gum composition
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0314617A1
    公开(公告)日:1989-05-03
    A gum composition is disclosed which has a substantially uniform soft chew from the initial chew, through the intermediate chew and on through the final chew. The gum composition can be a sugar or sugarless chewing gum composition or bubble gum composition. The gum compositions comprise a gum base, at least one sweetener, an acetylated monoglyceride, glycerin, and optionally, at least one additional conventional gum additive.
    本发明公开了一种口香糖组合物,从最初的咀嚼,到中间的咀嚼,再到最后的咀嚼,这种组合物具有基本均匀的软嚼感。口香糖组合物可以是含糖或无糖口香糖组合物,也可以是泡泡糖组合物。口香糖组合物包括口香糖基料、至少一种甜味剂、乙酰化单甘酯、甘油和可选的至少一种额外的常规口香糖添加剂。
  • Synergistic sweetening compositions containing chlorodeoxysugar and compositions containing same
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0354680A1
    公开(公告)日:1990-02-14
    Synergistic sweetening effect is produced by combination of a chlorodeoxysucrose sweetener such as sucralose with non-bitter intense dipeptide sweetener such as aspartame in the ratio of about 65:35 to about 91.7:8.3. The synergistic sweetening composition may be utilized in a wide variety of ingestible compositions.
    将氯代蔗糖甜味剂(如三氯蔗糖)与非苦味的强二肽甜味剂(如阿斯巴甜)按约 65:35 至约 91.7:8.3 的比例混合使用,可产生协同增甜效果。这种增效甜味剂组合物可用于多种可食用组合物中。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物